SEC Form 4 · accession 0001179110-15-005866
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Meury
Officer — See Remarks
Period of report
Apr 1, 2015
Accepted (ET)
Apr 2, 2015 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | Apr 1, 2015 | F | 3,848 | $296.19 | D | 74,192 | D | |
| Ordinary Shares, par value $0.0001F1 | Apr 1, 2015 | F | 1,788 | $296.19 | D | 72,404 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 15,689 restricted stock units.
Remarks
The Reporting Person is EVP Commercial, North American Brands of Actavis plc.